acipimox

This page covers all acipimox drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Hydroxycarboxylic acid receptor 2.

Targets

Hydroxycarboxylic acid receptor 2

Phase 3 pipeline (1)

• Olbemox · Gastroenterology
  Olbemox works by activating the hydroxycarboxylic acid receptor 2, which helps to reduce the production of triglycerides in the liver.

Patent intelligence

• acipimox patent landscape — aggregated cliff calendar, attackable patents, originator estates